Concepedia

Angelina I. Londoño

AI

Statistics

Publications

8

Citations

298

H-Index

8

Active since

2017

Affiliations

University of Alabama at Birmingham(Current)

HudsonAlpha Institute for Biotechnology

Angelina I. Londoño is an author at University of Alabama at Birmingham specializing in medicine, tumor immunity, and ovarian cancer.

Top concepts

Publications per year

2017–2021

8

Publications

8

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Rebecca C. Arend, Angelina I. Londoño, Allison M. Montgomery et al. · Molecular Cancer Research · 2018 · 59 citations

Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth

T.B. Turner, Selene Meza‐Perez, Angelina I. Londoño et al. · Oncotarget · 2017 · 52 citations · Full text

, , +11

Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy

Jaclyn Wall, Selene Meza‐Perez, Carly Bess Scalise et al. · Gynecologic Oncology · 2020 · 50 citations · Full text

, , +8

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer

David W. Doo, Selene Meza‐Perez, Angelina I. Londoño et al. · Therapeutic Advances in Medical Oncology · 2020 · 44 citations · Full text

The antitumor effects of entinostat in ovarian cancer require adaptive immunity

Haller J. Smith, Tyler R. McCaw, Angelina I. Londoño et al. · Cancer · 2018 · 31 citations · Full text

1–5 of 8